Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corneal Neovascularization: Pathogenesis, Current Insights and Future Strategies.

Biology·2026
Same author

The Immunobiology of Dry Eye Disease: A Review of the Pathogenesis, Regulation and Therapeutic Implications.

International journal of molecular sciences·2025
Same author

Assessing chatbots ability to produce leaflets on cataract surgery: Bing AI, chatGPT 3.5, chatGPT 4o, ChatSonic, Google Bard, Perplexity, and Pi.

Journal of cataract and refractive surgery·2025
Same author

The Ocular Surface and the Anterior Segment of the Eye in the Pseudoexfoliation Syndrome: A Comprehensive Review.

International journal of molecular sciences·2025
Same author

Adenylyl Cyclase in Ocular Health and Disease: A Comprehensive Review.

Biology·2024
Same author

The Role of Insulin-like Growth Factor (IGF) System in the Corneal Epithelium Homeostasis-From Limbal Epithelial Stem Cells to Therapeutic Applications.

Biology·2024

Related Experiment Video

Updated: Mar 29, 2026

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

1.5K

CRISPR and Beyond: Genome-Editing Strategies in Retinal Stem Cell Research.

Małgorzata Woronkowicz1,2, Maya Natasha Thomas1, Sarah Jacqueline Saram3

  • 1North Devon District Hospital, Royal Devon University Healthcare NHS Foundation Trust, Barnstaple EX31 4JB, UK.

Cells
|March 27, 2026
PubMed
Summary

Genome editing, particularly CRISPR-Cas9, combined with pluripotent stem cells, offers powerful tools for studying and treating retinal degenerative diseases through advanced gene editing techniques.

Keywords:
CRISPR-Cas9ESCsTALENsZFNsbase editingiPSCsprime editingretinastem cells

More Related Videos

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

14.3K
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

34.5K

Related Experiment Videos

Last Updated: Mar 29, 2026

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases
07:46

Author Spotlight: Advancing Vision Restoration - Stem Cell-Based Therapy for Retinal Diseases

Published on: October 6, 2023

1.5K
Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation
09:51

Establishment of Genome-edited Human Pluripotent Stem Cell Lines: From Targeting to Isolation

Published on: February 2, 2016

14.3K
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

34.5K

Area of Science:

  • Ophthalmology and Genetics
  • Stem Cell Biology
  • Biotechnology

Background:

  • Retinal degenerative diseases pose significant challenges to vision health.
  • Genome editing technologies have advanced rapidly, offering new therapeutic avenues.
  • Pluripotent stem cells provide a valuable platform for disease modeling and therapeutic development.

Purpose of the Study:

  • To provide a comprehensive overview of genome editing techniques in retinal research.
  • To highlight the application of CRISPR-Cas9, base editing, and prime editing in stem cells.
  • To discuss the use of these technologies for disease modeling and therapeutic strategies in inherited retinal diseases.

Main Methods:

  • Review of current literature on genome editing techniques (CRISPR-Cas9, base editing, prime editing).
  • Focus on the use of induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs).
  • Analysis of studies applying gene editing for retinal disease modeling and therapeutic development.

Main Results:

  • Genome editing in combination with pluripotent stem cells enables robust modeling of human retinal diseases.
  • CRISPR-Cas9, base editing, and prime editing show promise for correcting disease-causing mutations.
  • Clinically relevant models are being developed for functional studies and therapeutic strategy investigation.

Conclusions:

  • Genome editing in pluripotent stem cells is a transformative approach for retinal disease research.
  • Continued refinement of gene editing techniques is crucial for advancing translational applications.
  • This technology holds significant potential for developing targeted therapies for inherited retinal conditions.